Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kolosova, O. Tsvetkova, E. Ilina, M. Atroshkina (Moscow, Russian Federation). The role of bacterial pathogens in exacerbation of COPD assessed by microbiological method and polymerase chain reaction. Eur Respir J 2008; 32: Suppl. 52, 2750

Member's Comments

No comment yet.

Related content which might interest you: Viral and bacterial etiologies in acute exacerbation of COPD detected using a multiplex real-time polymerase chain reaction Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Real time polymerase chain reaction versus conventional culture method to detect respiratory pathogens in subjects with non-cystic fibrosis bronchiectasis. Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Efficiency of use real-time polymerase chain reaction in differential diagnostics of the tuberculosis and the lung cancer Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 Multiplex real-time polymerase chain reaction is useful in diagnosing pathogens causing community-acquired pneumonia including atypical bacteria and viruses Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Etiologies of acute exacerbation of bronchial asthma in adults by real-time polymerase chain reaction Source: Annual Congress 2013 –Asthma Year: 2013 Usefulness of multiplex real-time polymerase chain reaction for diagnosing community acquired pneumonia in Japanese adults Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Does polymerase chain reaction (PCR) increase diagnostic yield in the investigation of community-acquired lower respiratory tract illness (LRTI)? Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001 Comparison of quantitative PCR and quantitative culture for the detection of airway pathogenic bacteria in COPD Source: International Congress 2014 – Markers Year: 2014 Is polymerase chain reaction (PCR) an alternative for broncoscopy in patients with sputum smear negative pulmonary tuberculosis? Source: Eur Respir J 2004; 24: Suppl. 48, 425s Year: 2004 Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis Source: Eur Respir J 2007; 30: 508-516 Year: 2007 Detection of Mycobacterium tuberculosis in sputum samples using polymerase chain reaction (PCR) Source: Eur Respir J 2001; 18: Suppl. 33, 496s Year: 2001 Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases Source: Eur Respir J 2003; 21: 944-951 Year: 2003 Diagnostic value of polymerase chain reaction (PCR) in the management of pediatric tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 581s Year: 2002 Assessment of sputum Mycobacterium tuberculosis messenger RNA levels in anti-microbial treatment monitoring Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005 Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area Source: Eur Respir J 2004; 23: 446-451 Year: 2004 Rapid detection of major respiratory tract viral infections in acute exacerbation of COPD by highly sensitive multiplex PCR (mPCR) Source: Annual Congress 2013 –Viral infections Year: 2013 Identification of causative bacteria in the airways of COPD by a novel semi-quantitative PCR method Source: Annual Congress 2013 –COPD and infections Year: 2013 Use of a multiplex real-time PCR for differential diagnosis of respiratory viral infections Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009 Diagnostic value of high fever to predict polymerase chain reaction (PCR) status in patients with Novel Coronavirus (COVID-19) pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Diagnostic performance of multiplex bacterial PCR in BAL for bacterial pneumonia varies across molecular assays Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020